Meeting Banner
Abstract #1464

Towards Optimization of DCE-MRI Analysis for Early Prediction of the Response of Breast Cancer Patients to Neoadjuvant Chemotherapy

Xia Li1, Lori R. Arlinghaus1, A. Bapsi chakravarthy1, E. Brian Welch1, Jaime Farley1, Ingrid A. Mayer1, Vandana G. Abramson1, Richard G. Abramson1, Mark C. Kelley1, Ingrid M. Meszoely1, Julie A. Means-Powell1, Ana M. Grau1, Sandeep Bhave1, Thomas E. Yankeelov1

1Vanderbilt University Institute of Imaging Science, Nashville, TN, United States

Tumor response to neoadjuvant chemotherapy is currently monitored by frank changes in tumor size, which often do not correlate with pathologic findings at surgery. DCE-MRI offers information related to tumor perfusion and permeability, vascular volume, and extravascular extracellular volume fraction. In this study, we attempted to determine the optimal analysis method for assessing if changes in these parameters after one cycle of therapy could separate pathologic complete responders from non-responders. The results show that tumor perfusion and permeability and vascular volume yield significant differences between responders and non-responders, but that changes in tumor volume do not.

Abstract PDF Poster PDF

Keywords

ability able achieving acknowledgments acquisition allow approved assessing attempted basis best breast cancer chemotherapy clinical clinicians collected combined complete contrast contribute correlate currently cycle determine developing deviation disease displaying displays dynamic early eight eleven employed enhanced enhancing enrolled equally exam example exchange extended extracellular fast findings fraction gradient important indicating individual injected institute intracellular lead lifetime lists literature mark matrix mayer measured median model models molecule monitored nearly note offers often optimal optimization outperform particular pathologic patient patients perfusion permeability physical physiological population predict prediction predictor quantitative radiology rank regime related reported residual respectively responders response scanner science sensitive separate serial setting several significance slice spoiled stage statistically summarizing surgery table tailor therapy towards treatment trial tumor ultimately ultrasound variables vascular volume water ways